Results 211 to 220 of about 29,245 (221)

Topoisomerase I Inhibitors

Oncologist, 1997
Mark J Ratain, Ratain Mark J
exaly  

[Topoisomerase II inhibitors (anthracyclines)].

Nihon rinsho. Japanese journal of clinical medicine, 2015
Atsushi, Sato, Takenori, Takahata, Kensuke, Saito   +2 more
openaire   +1 more source

ATP-competitive DNA gyrase and topoisomerase IV inhibitors as antibacterial agents

Expert Opinion on Therapeutic Patents, 2019
Martina Ďurčík, Tihomir Tomasic, Nace Zidar   +2 more
exaly  

Topoisomerase II inhibitor induced leukemia in a patient with AIDS

AIDS, 2001
S, Nabil, F, Thomas, R, Douglas, B, Michael   +3 more
openaire   +2 more sources

Emerging DNA topoisomerase inhibitors as anticancer drugs

Expert Opinion on Emerging Drugs, 2004
William A Denny
exaly  

Discovery of a new class of catalytic topoisomerase II inhibitors targeting the ATP-binding site by structure based design. Part I

Bioorganic and Medicinal Chemistry Letters, 2009
Pascal Furet, Joseph Schoepfer, Thomas Radimerski   +2 more
exaly  

Cystobactamids: Myxobacterial Topoisomerase Inhibitors Exhibiting Potent Antibacterial Activity

Angewandte Chemie - International Edition, 2014
Jennifer Herrmann, Ritesh Raju, Heinrich Steinmetz   +2 more
exaly  

DNA topoisomerase II inhibitors.

IARC monographs on the evaluation of carcinogenic risks to humans, 2001
openaire   +1 more source

Topoisomerase II inhibitors

Update on Cancer Therapeutics, 2008
exaly  

DNA topoisomerase II poisons and inhibitors.

Cancer chemotherapy and biological response modifiers, 1998
G, Capranico, G, Giaccone, F, Zunino, S, Garattini, M, D'Incalci   +4 more
openaire   +1 more source